320 related articles for article (PubMed ID: 9443042)
21. Absence of PTEN/MMAC1 germ-line mutations in sporadic Bannayan-Riley-Ruvalcaba syndrome.
Carethers JM; Furnari FB; Zigman AF; Lavine JE; Jones MC; Graham GE; Teebi AS; Huang HJ; Ha HT; Chauhan DP; Chang CL; Cavenee WK; Boland CR
Cancer Res; 1998 Jul; 58(13):2724-6. PubMed ID: 9661881
[TBL] [Abstract][Full Text] [Related]
22. [Cowden disease].
Sawada T; Hamano N; Suzuki A; Okada T; Mabuchi H
Nihon Rinsho; 2000 Jul; 58(7):1479-83. PubMed ID: 10921327
[TBL] [Abstract][Full Text] [Related]
23. A heterozygous germline mutation of the PTEN/MMAC1 gene in a patient with Cowden disease.
Iida S; Nakamura Y; Fujii H; Kimura M; Moriwaki K
Int J Mol Med; 1998 Mar; 1(3):565-8. PubMed ID: 9852263
[TBL] [Abstract][Full Text] [Related]
24. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
[TBL] [Abstract][Full Text] [Related]
25. PTEN mutations in eight Spanish families and one Brazilian family with Cowden syndrome.
Bussaglia E; Pujol RM; Gil MJ; Martí RM; Tuneu A; Febrer MI; Garcia-Patos V; Ruiz EM; Barnadas M; Alegre M; Serrano S; Matias-Guiu X
J Invest Dermatol; 2002 Apr; 118(4):639-44. PubMed ID: 11918710
[TBL] [Abstract][Full Text] [Related]
26. Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma.
Van Gele M; Leonard JH; Van Roy N; Cook AL; De Paepe A; Speleman F
Int J Cancer; 2001 May; 92(3):409-13. PubMed ID: 11291079
[TBL] [Abstract][Full Text] [Related]
27. Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways.
Yeh JJ; Marsh DJ; Zedenius J; Dwight T; Delbridge L; Robinson BG; Eng C
Genes Chromosomes Cancer; 1999 Dec; 26(4):322-8. PubMed ID: 10534767
[TBL] [Abstract][Full Text] [Related]
28. Analysis of PTEN gene mutations in Korean patients with Cowden syndrome and polyposis syndrome.
Kim DK; Myung SJ; Yang SK; Hong SS; Kim KJ; Byeon JS; Lee GH; Kim JH; Min YI; Lee SM; Jeong JY; Song K; Jung SA
Dis Colon Rectum; 2005 Sep; 48(9):1714-22. PubMed ID: 16007494
[TBL] [Abstract][Full Text] [Related]
29. A novel loss-of-function mutation (N48K) in the PTEN gene in a Spanish patient with Cowden disease.
Vega A; Torres J; Torres M; Cameselle-Teijeiro J; Macia M; Carracedo A; Pulido R
J Invest Dermatol; 2003 Dec; 121(6):1356-9. PubMed ID: 14675182
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of germline PTEN mutations in endometrial cancer patients.
Black D; Bogomolniy F; Robson ME; Offit K; Barakat RR; Boyd J
Gynecol Oncol; 2005 Jan; 96(1):21-4. PubMed ID: 15589575
[TBL] [Abstract][Full Text] [Related]
31. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
Dahia PL; Marsh DJ; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
Cancer Res; 1997 Nov; 57(21):4710-3. PubMed ID: 9354427
[TBL] [Abstract][Full Text] [Related]
32. Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer.
FitzGerald MG; Marsh DJ; Wahrer D; Bell D; Caron S; Shannon KE; Ishioka C; Isselbacher KJ; Garber JE; Eng C; Haber DA
Oncogene; 1998 Aug; 17(6):727-31. PubMed ID: 9715274
[TBL] [Abstract][Full Text] [Related]
33. [Cowden disease and the PTEN gene: a successfully clinical and biological combined approach].
Longy M
Bull Cancer; 2001 Dec; 88(12):1153-8. PubMed ID: 11792608
[TBL] [Abstract][Full Text] [Related]
34. The PTEN tumour suppressor gene and malignant melanoma.
Böni R; Vortmeyer AO; Burg G; Hofbauer G; Zhuang Z
Melanoma Res; 1998 Aug; 8(4):300-2. PubMed ID: 9764804
[TBL] [Abstract][Full Text] [Related]
35. Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease.
Arch EM; Goodman BK; Van Wesep RA; Liaw D; Clarke K; Parsons R; McKusick VA; Geraghty MT
Am J Med Genet; 1997 Sep; 71(4):489-93. PubMed ID: 9286463
[TBL] [Abstract][Full Text] [Related]
36. Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles.
Kurose K; Bando K; Fukino K; Sugisaki Y; Araki T; Emi M
Jpn J Cancer Res; 1998 Aug; 89(8):842-8. PubMed ID: 9765621
[TBL] [Abstract][Full Text] [Related]
37. Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer.
Cooney KA; Tsou HC; Petty EM; Miesfeldt S; Ping XL; Gruener AC; Peacocke M
Clin Cancer Res; 1999 Jun; 5(6):1387-91. PubMed ID: 10389923
[TBL] [Abstract][Full Text] [Related]
38. Cowden's disease: clinical and molecular genetic findings in a patient with a novel PTEN germline mutation.
Reifenberger J; Rauch L; Beckmann MW; Megahed M; Ruzicka T; Reifenberger G
Br J Dermatol; 2003 May; 148(5):1040-6. PubMed ID: 12786840
[TBL] [Abstract][Full Text] [Related]
39. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes.
Pezzolesi MG; Li Y; Zhou XP; Pilarski R; Shen L; Eng C
Am J Hum Genet; 2006 Nov; 79(5):923-34. PubMed ID: 17033968
[TBL] [Abstract][Full Text] [Related]
40. Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM
Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
